Literature DB >> 10334911

Identification of three alternatively spliced variants of human CD28 mRNA.

G Magistrelli1, P Jeannin, G Elson, J F Gauchat, T N Nguyen, J Y Bonnefoy, Y Delneste.   

Abstract

CD28, expressed by T cells, plays a central role in providing costimulatory signals to T cells. The cd28 gene is organized into 4 exons. An alternatively spliced CD28 mRNA lacking most of the exon 2 has been previously evidenced. We report here that non stimulated human T cells express three additional alternatively spliced variants of CD28 mRNA (CD28a-c) in. The CD28a variant, expressed at similar levels to that of the full length CD28 mRNA encoding for the membrane form, lacks exon 3. This deletion introduces (i) a frame shift resulting in the addition of two extra amino acids and a premature stop codon and, (ii) induces the loss of the transmembrane region, suggesting that it could encodes for a soluble monomeric molecule which conserves the binding sites of CD28. The CD28b and CD28c variants, expressed at a low level compared with CD28a, are generated by deletion of most of the 3' end of exon 2 plus exon 3 and exon 2 plus exon 3, respectively. Activated T cells express only the membrane CD28 mRNA. These results suggest that resting human T cells may constitutively express both membrane and soluble CD28 which can differentially regulate the outcome of the T cell response. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10334911     DOI: 10.1006/bbrc.1999.0725

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

Review 1.  Immunogenomics and systems biology of vaccines.

Authors:  Luigi Buonaguro; Bali Pulendran
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

2.  Aberrant expression of soluble co-stimulatory molecules and adhesion molecules in type 2 diabetic patients with nephropathy.

Authors:  C K Wong; Amy W Y Ho; Peter C Y Tong; C Y Yeung; Juliana C N Chan; Alice P S Kong; Christopher W K Lam
Journal:  J Clin Immunol       Date:  2007-11-17       Impact factor: 8.317

3.  Potentiating functional antigen-specific CD8⁺ T cell immunity by a novel PD1 isoform-based fusion DNA vaccine.

Authors:  Jingying Zhou; Allen Kl Cheung; Henggui Liu; Zhiwu Tan; Xian Tang; Yuanxi Kang; Yanhua Du; Haibo Wang; Li Liu; Zhiwei Chen
Journal:  Mol Ther       Date:  2013-04-16       Impact factor: 11.454

4.  Increased expression of plasma and cell surface co-stimulatory molecules CTLA-4, CD28 and CD86 in adult patients with allergic asthma.

Authors:  C K Wong; S W M Lun; F W S Ko; W K Ip; D S C Hui; C W K Lam
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

5.  Increased CD28 serum levels are not associated with specific clinical activity in systemic lupus erythematosus.

Authors:  Aniel J L Brambila-Tapia; Jorge I Gámez-Nava; Mario Salazar-Páramo; José F Munoz-Valle; Laura González-López; Mara A Llamas-Covarrubias; Sergio R Gutiérrez-Urena; Mónica Vázquez-Del Mercado; Ingrid P Dávalos-Rodríguez
Journal:  Rheumatol Int       Date:  2011-10       Impact factor: 2.631

6.  Lack of intrinsic CTLA-4 expression has minimal effect on regulation of antiviral T-cell immunity.

Authors:  Dirk Homann; Wolfgang Dummer; Tom Wolfe; Evelyn Rodrigo; Argyrios N Theofilopoulos; Michael B A Oldstone; Matthias G von Herrath
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

7.  Detection of circulating soluble CD28 in patients with systemic lupus erythematosus, primary Sjögren's syndrome and systemic sclerosis.

Authors:  M Hebbar; P Jeannin; G Magistrelli; P-Y Hatron; E Hachulla; B Devulder; J-Y Bonnefoy; Y Delneste
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

8.  CD40 and CD80/86 act synergistically to regulate inflammation and mortality in polymicrobial sepsis.

Authors:  Anna Nolan; Michael Weiden; Ann Kelly; Yoshihiko Hoshino; Satomi Hoshino; Nehal Mehta; Jeffrey A Gold
Journal:  Am J Respir Crit Care Med       Date:  2007-11-07       Impact factor: 21.405

9.  CD28-B7 interaction modulates short- and long-lived plasma cell function.

Authors:  Modesta N Njau; Jin Hyang Kim; Craig P Chappell; Rajesh Ravindran; Leela Thomas; Bali Pulendran; Joshy Jacob
Journal:  J Immunol       Date:  2012-08-20       Impact factor: 5.422

10.  Cytotoxic T lymphocyte-Associated Antigen +49G Variant Confers Risk for Anti-CCP- and Rheumatoid Factor-Positive Type of Rheumatoid Arthritis Only in Combination with CT60G Allele.

Authors:  Bernadett Farago; Peter Kisfali; Lili Magyari; Noemi Polgar; Bela Melegh
Journal:  Autoimmune Dis       Date:  2009-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.